Geneaty Therapeutics, Inc. is a biopharmaceutical start-up company located in Austin, Texas. Our vision is to revolutionize biologic therapies of chronic and infectious diseases s using cutting-edge nanotechnology.
Our key personnel include the inventors of the technologies with combined experience of more than 30 years nanotechnology, oncology and vaccine research. In addition, our clinical, business and industrial advisers have substantial research and clinical experience in early phase novel immunotherapies and combinations.
Unfortunately, immunotherapies are associated with various adverse events, largely due to their non-specific, unwanted activities in healthy tissues. This limits the use of immunotherapies in patients with autoimmune diseases, poor performance status, as well as elderly and frail patients, due to their potential toxicities in these populations.
Our novel platform technology can transform monoclonal antibody (mAb) into new formulations with more targeted distribution in inflammation sites, thereby reducing the adverse events associated with the current therapies.
Our RNAi technology consist of novel lipid nanoparticles that can 1) increase the distribution of siRNAs in inflammation sites, 2) limit the release of siRNA to the cytoplasm inside the targeted cells.
Austin, Texas , United States
Copyright © 2020 Geneaty Therapeutics. Inc. - All Rights Reserved.
Gene-aty ,therapies according to you